Achmad Lefi

Dr. Achmad Lefi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MAMochamad Yusuf Alsagaff
Mochamad Yusuf Alsagaff
LWLouisa Fadjri Kusuma Wardhani
Louisa Fadjri Kusuma Wardhani
RNRicardo Adrian Nugraha
Ricardo Adrian Nugraha
TPTony Santoso Putra
Tony Santoso Putra
BKBagus Putra Khrisna
Bagus Putra Khrisna
BPBudi Susetyo Pikir
Budi Susetyo Pikir
Background. Myocardial involvement among critically ill patients with coronavirus disease 2019 (COVID-19) often has worse outcomes. An imbalance in the oxygen supply causes the excessive release of pro-inflammatory cytokines, which results in increased ventilation requirements and the risk of death in COVID-19 patients. Purpose. We evaluated the association between the hs-troponin I levels and global longitudinal strain (GLS) as evidence of myocardial involvement among critical COVID-19 patients. Methods. We conducted a prospective cohort study from 1 February to 31 July 2021 at RSUD Dr. Soetomo, Surabaya, as a COVID-19 referral center. Of the 65 critical COVID-19 patients included, 41 (63.1%) were men, with a median age (interquartile range) of 51.0 years (20.0–75.0). Subjects were recruited based on WHO criteria for severe COVID-19, and myocardial involvement in the form of myocarditis was assessed using CDC criteria. Subjects were examined using echocardiography to measure the GLS, and blood samples were taken to measure the hs-troponin. Subjects were then followed for their need for mechanical ventilation and in-hospital mortality. Results. Severe COVID-19 patients with cardiac injury were associated with an increased need for intubation (78.5%) and an increased incidence of myocarditis (50.8%). There was a relationship between the use of intubation and the risk of death in patients (66.7% vs. 33.3%, p-value < 0.001). Decreased GLS and increased hs-troponin were associated with increased myocarditis (p values < 0.001 and 0.004, respectively). Decreased GLS was associated with a higher need for mechanical ventilation (12.17 + 4.79 vs. 15.65 + 4.90, p-value = 0.02) and higher mortality (11.36 + 4.64 vs. 14.74 + 4.82; p-value = 0.005). Elevated hs-troponin was associated with a higher need for mechanical ventilation (25.33% vs. 3.56%, p-value = 0.002) and higher mortality (34.57% vs. 5.76%, p-value = 0.002). Conclusions. Critically ill COVID-19 patients with myocardial involvement and elevated cardiac troponin levels are associated with a higher need for mechanical ventilation and higher mortality.

1 December 2024 in Journal of Medicinal and Chemical Sciences
Verified
Other
Open access
PDF file
YOYudi Her Oktaviono
Yudi Her Oktaviono
ALAchmad Lefi
Achmad Lefi
LDLucia Kris Dinarti
Lucia Kris Dinarti
BWBambang Widyantoro
Bambang Widyantoro
TMTita Rifatul Mahmudah
Tita Rifatul Mahmudah
MAMakhyan Jibril Al-Farabi
Makhyan Jibril Al-Farabi
Fibrosis of the heart valves is a progressive pathological process in rheumatic heart disease (RHD) that can cause permanent disability, characterized by valve interstitial cells (VICs) differentiation into myofibroblast. In rheumatic heart disease patients (RHD), heart valve cells contain substantially increased levels of high-sensitivity C-reactive protein (CRP), TGF-β1, IL-6, TNF-α, and IL-1β, compared to those in healthy individuals. A variety of studies have illustrated TGF-β1's involvement in differentiating myofibroblasts from VICs, yet research on the influence of other cytokines in the fibrosis of heart valves remains limited. This study explored the induction effects of TGF-β1, IL-6, TNF-α, and IL-1β on VICs isolated from New Zealand rabbits (Oryctolagus cuniculus) and established an in vitro model of myofibroblast differentiation, marked by α-smooth muscle actin (α-SMA) expression. A laboratory experiment employing a posttest-only control group design was performed in vitro. VICs were extracted from the heart valves of Oryctolagus cuniculus and later stimulated with (1) 10 ng/mL IL-1β, (2) 50 ng/mL IL-6, (3) 5 ng/mL TGF-β1, and (4) 10 ng/mL TNF-α. The expression of α-SMA, observed via immunocytochemistry, was used to indicate the differentiation of VICs into myofibroblasts. Immunochemical staining showed significantly increased myofibroblast differentiation across all intervention groups, with a mean α-SMA expression increase of 12.70 for IL-1β, 12.64 for IL-6, 12.48 for TGF-β1, and 12.48 for TNF-α as opposed to each control group (p < 0.001). No variance in α-SMA concentration was observed among intervention groups. The four tested cytokines had similar effects in inducing the differentiation of VICs into myofibroblast, as expressed by α-SMA. These findings may serve as an in vitro model of valvular fibrosis and encourage further research into inhibiting valve fibrosis caused by RHD.

9 November 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ALAchmad Lefi
Achmad Lefi
DSDenny Suwanto
Denny Suwanto
BDBudi Baktijasa Dharmadjati
Budi Baktijasa Dharmadjati
YOYudi Her Oktaviono
Yudi Her Oktaviono
ASAgus Subagjo
Agus Subagjo
RNRicardo Adrian Nugraha
Ricardo Adrian Nugraha
Background. Recent studies revealed that differentiation of valvular interstitial cell into myofibroblasts played an important role in pathological valve remodeling in rheumatic valvular disease. Objective. To investigate effects of atorvastatin, olmesartan, and resveratrol on Transforming Growth Factor β1-induced fibrosis. Methods. Valvular interstitial cell was isolated from 12-weeks male New Zealand rabbit (Oryctolagus cuniculus). Culture cells was divided into 4 groups, control group, group I (0.5 mg/mL Atorvastatin), group II (100 nmol/L Olmesartan), group III (50 μM/L Resveratrol) and group IV (combinations). All group were exposed to 100 nM Transforming Growth Factor β1 for 24 hours. Results. Immunochemical staining demonstrated that cells were completely differentiated into myofibroblasts with mean expression of α-smooth muscle actin 24522.64±4566.994. Atorvastatin, olmesartan, resveratrol, and its combination significantly reduced α-smooth muscle actin expression (6823±1735.3, 6942.7±2455.9, 14176.2±3343.3, 5051.8±1612.2 respectively (p<0.001). Conclusion. Our data showed atorvastatin, olmesartan, resveratrol, and its combination significantly reduce Transforming Growth Factor β1-induced valvular fibrosis.

10 January 2026 in JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
Verified
Journal Article
Open access
DKDian Paramita Kartikasari
Dian Paramita Kartikasari
ALAchmad Lefi
Achmad Lefi
IKIrawati Hajar Kikuko
Irawati Hajar Kikuko
ALAsri Laksitarini
Asri Laksitarini
PSPandit Bagus Tri Saputra
Pandit Bagus Tri Saputra
EAEmildha Dwi Agustina
Emildha Dwi Agustina
Highlights: Rheumatic heart disease remains a significant health concern in low-and middle-income countries, as it is often challenging to detect in its early stages due to subtle or absent symptoms, particularly during the subclinical phase. Task-shifting echocardiographic screening of RHD to GPs offers a scalable solution in low-resource settings. Abstract Introduction: Rheumatic heart disease (RHD) remains a significant health burden in low- and middle-income countries. Early detection of RHD by trained general practitioners (GPs) enables earlier intervention to prevent disease progression. This study aimed to evaluate the feasibility and effectiveness of training non-expert health workers in Indonesia to perform echocardiographic screening for RHD, addressing the country’s unique challenges and bridging the gap in healthcare resources. Methods: A quasi-experimental pre-post intervention study was conducted involving 18 GPs with no prior echocardiography experience. The training consisted of one day of lecture-based instruction and six days of supervised hands-on practice. Knowledge was assessed using a newly developed RHD-echocardiography test that underwent face and content validation by two cardiologists and demonstrated good internal consistency (Cronbach’s alpha = 0.82). Pre- and post-training knowledge was compared using paired t-tests. Diagnostic sensitivity and specificity were calculated using cardiologist-confirmed findings from a subsequent one-month school-based screening of 440 students. Results: The mean pre-test score was 64 ± 11, significantly increasing to 95 ± 7.5 after training (p<0.001). Image quality was diagnostically adequate in 97.7% of examinations. Sensitivity and specificity of GP-acquired screening echocardiograms were 41.4% (95% Confidence Interval/CI: 29.9%-53.0%) and 73.7% (95% CI: 69.1%-78.3%), respectively. No significant differences in scores were observed by gender or age group. Conclusion: Although participants initially had limited exposure to echocardiography, the structured short-term curriculum substantially improved knowledge, image acquisition skills, and screening capability. Task-shifting echocardiographic screening to mid-level providers appears feasible in Indonesia and warrants further refinement and scale-up.

15 January 2025 in The Journal of Tehran University Heart Center
Verified
Journal Article
Open access
ALAchmad Lefi
Achmad Lefi
DADenisa Nugrahita Asmarani
Denisa Nugrahita Asmarani
BDBudi Baktijasa Dharmadjati
Budi Baktijasa Dharmadjati
DSDenny Suwanto
Denny Suwanto
MSMahendra Eko Saputra
Mahendra Eko Saputra
FAFaizal Ablansah Anandita
Faizal Ablansah Anandita
Background: Rheumatic heart disease (RHD) is exacerbated by chronic inflammation that stimulates the release of proinflammatory cytokines, most notably transforming growth factor-beta 1 (TGF-β1), which promotes myofibroblast differentiation. This study aims to determine the optimal dosage of Lisinopril, an angiotensin-converting enzyme inhibitor, for mitigating the fibrotic changes associated with RHD. Methods: This in vitro, posttest-only control group study involved obtaining valvular interstitial cells from the heart valves of 25 male New Zealand rabbits (Oryctolagus cuniculus). Valvular interstitial cells were divided into 5 groups: a control group exposed to TGF-β1, and 4 experimental groups exposed to various Lisinopril doses (1 µM, 10 µM, and 100 µM) in addition to TGF-β1. The effect of Lisinopril on myofibroblast differentiation was assessed by measuring alpha-smooth muscle actin (αSMA) expression through immunocytochemical methods. Statistical significance was determined using an independent T-test with a P value of less than 0.050. Results: Independent T-tests conducted on 25 male Oryctolagus cuniculus demonstrated significantly lower αSMA expression in the groups treated with various Lisinopril doses (1 µM, 10 µM, and 100 µM) compared with the TGF-β1-induced control group (P<0.050). The most significant reduction in αSMA expression was observed in the group treated with the highest Lisinopril dose of 100 µM. Conclusion: Lisinopril demonstrates a significant ability to inhibit TGF-β1-induced myofibroblast differentiation in rabbit valve interstitial cells, with the 100 µM dose proving most effective. These results suggest that Lisinopril may have the potential to curb RHD progression, warranting further investigations in vivo.

1 April 2026
Verified
Journal Article
Open access
YSYan Efrata Sembiring
Yan Efrata Sembiring
LDLyndon Darwin
Lyndon Darwin
ALAchmad Lefi
Achmad Lefi
PLPudji Lestari
Pudji Lestari
FAFan Maitri Aldian
Fan Maitri Aldian
Despite advancements in technique and the increasing number of coronary artery bypass grafting (CABG) procedures, new-onset postoperative atrial fibrillation (POAF) is one of the most common complications following CABG and remains a major concern. The exact mechanism is unclear, but impaired diastolic function may predispose patients to POAF. Thus, this study aims to evaluate preoperative diastolic dysfunction (DD) and associated factors as predictors of new-onset POAF. This retrospective cohort study involved patients undergoing CABG surgery who met the inclusion criteria between January 2018 to August 2022. DD was measured through preoperative transthoracic echocardiogram, while new-onset POAF was assessed through continuous electrocardiogram. A total of 191 patients who met the inclusion criteria were enrolled in this study. Data-analysis revealed no significant difference in DD between patients with and without POAF (P = 0.72). Multivariate analysis demonstrated left main coronary artery disease (LMCAD) (odds ratio [OR] = 2.51; 95% confidence interval [CI] [1.12 - 5.59]; P = 0.02), in-stent restenosis (ISR) ≥ 70% (OR = 6.34; 95% CI [1.68 - 23.92]; P < 0.01), reduced ejection fraction ≤ 50% (OR = 2.18; 95% CI [0.94 - 5.06]; P = 0.07), and electrolyte imbalance (OR = 2.14; 95% CI [2.91 - 24.75]; P < 0.01) as the independent predictors of new-onset POAF. DD was not identified as a predictor of new-onset POAF in patients undergoing CABG. The independent predictors identified in this study included male sex, comorbid LMCAD and ISR ≥ 70%, reduced left ventricular ejection fraction ≤ 50%, and postoperative electrolyte imbalance.